Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Signal transduction and oncogenesis by ErbB/HER receptors.

Marmor MD, Skaria KB, Yarden Y.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):903-13. Review.

PMID:
14967450
[PubMed - indexed for MEDLINE]
2.

Feedback inhibition by RALT controls signal output by the ErbB network.

Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, Castellani L, Alemà S, Alimandi M, Segatto O.

Oncogene. 2003 Jul 3;22(27):4221-34.

PMID:
12833145
[PubMed - indexed for MEDLINE]
3.

Bivalence of EGF-like ligands drives the ErbB signaling network.

Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y.

EMBO J. 1997 Aug 15;16(16):4938-50.

PMID:
9305636
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.

Stancovski I, Peles E, Ben Levy R, Lemprecht R, Kelman Z, Goldman-Michael R, Hurwitz E, Bacus S, Sela M, Yarden Y.

J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):95-103. Review.

PMID:
1356018
[PubMed - indexed for MEDLINE]
6.

Role of HER receptors family in development and differentiation.

Casalini P, Iorio MV, Galmozzi E, Ménard S.

J Cell Physiol. 2004 Sep;200(3):343-50. Review.

PMID:
15254961
[PubMed - indexed for MEDLINE]
7.

Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.

Sweeney C, Carraway KL 3rd.

Oncogene. 2000 Nov 20;19(49):5568-73. Review.

PMID:
11114736
[PubMed - indexed for MEDLINE]
Free Article
8.

Radiotherapy-induced signal transduction.

Yacoub A, Miller A, Caron RW, Qiao L, Curiel DA, Fisher PB, Hagan MP, Grant S, Dent P.

Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S99-114.

PMID:
17259563
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.

Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI.

Oncogene. 1994 Aug;9(8):2109-23. Review.

PMID:
7913542
[PubMed - indexed for MEDLINE]
11.

ON-III inhibits erbB-2 tyrosine kinase receptor signal pathway and triggers apoptosis through induction of Bim in breast cancer cells.

Li DD, Wu XQ, Tang J, Wei XY, Zhu XF.

Cancer Biol Ther. 2009 Apr;8(8):739-43. Epub 2009 Apr 22.

PMID:
19242112
[PubMed - indexed for MEDLINE]
Free Article
12.

The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention.

Citri A, Kochupurakkal BS, Yarden Y.

Cell Cycle. 2004 Jan;3(1):51-60. Review.

PMID:
14657666
[PubMed - indexed for MEDLINE]
Free Article
13.

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.

Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O.

Mol Cancer Ther. 2007 Mar;6(3):1123-32.

PMID:
17363505
[PubMed - indexed for MEDLINE]
Free Article
14.

Oncogenic growth factor receptors: implications for signal transduction therapy.

Mosesson Y, Yarden Y.

Semin Cancer Biol. 2004 Aug;14(4):262-70. Review.

PMID:
15219619
[PubMed - indexed for MEDLINE]
15.

SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells.

Zhu XF, Wang JS, Cai LL, Zeng YX, Yang D.

Cancer Sci. 2006 Jan;97(1):84-9.

PMID:
16367926
[PubMed - indexed for MEDLINE]
16.

The ErbB/HER receptor protein-tyrosine kinases and cancer.

Roskoski R Jr.

Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. Review.

PMID:
15158434
[PubMed - indexed for MEDLINE]
17.

Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Huang Y, Li X, Jiang J, Frank SJ.

Oncogene. 2006 Dec 7;25(58):7565-76. Epub 2006 Jun 19.

PMID:
16785991
[PubMed - indexed for MEDLINE]
18.

Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration.

Sewell JM, Smyth JF, Langdon SP.

Exp Cell Res. 2005 Mar 10;304(1):305-16. Epub 2004 Dec 9.

PMID:
15707595
[PubMed - indexed for MEDLINE]
19.

Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication.

Argast GM, Campbell JS, Brooling JT, Fausto N.

J Biol Chem. 2004 Aug 13;279(33):34530-6. Epub 2004 Jun 15.

PMID:
15199050
[PubMed - indexed for MEDLINE]
Free Article
20.

p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal.

Diehl KM, Grewal N, Ethier SP, Woods-Ignatoski KM.

J Surg Res. 2007 Sep;142(1):162-9. Epub 2007 Jul 5.

PMID:
17612563
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk